The Canadian ALS Research Network (CALS), a group of ALS clinicians and researchers across Canada, will be holding a webinar offering perspectives on ALS treatments including edaravone as well as others in development. The webinar will be a panel discussion featuring:
- Dr. Wendy Johnston, Director of the Edmonton ALS Clinic and Co-Chair of CALS
- Dr. Geneviève Matte, Director of the ALS Clinic at CHUM – Hôpital Notre-Dame
- Dr. Colleen O’Connell, Director of the Fredericton ALS Clinic and Co-Chair of CALS
- Dr. Christen Shoesmith, Director of the London ALS Clinic
The webinar will be moderated by Dr. David Taylor, Vice President Research for ALS Canada, which is sponsoring the webinar. He will provide a brief overview of edaravone, masitinib, NurOwn, tirasemtiv and other experimental treatments currently in clinical trials.
Questions for the panel can be submitted in advance by email to firstname.lastname@example.org or during the webinar itself using the webinar control panel. Questions can be submitted either in English or French.